OTC News

Cigarette smoking is a well-known risk factor for type 2 diabetes, but new research from Johns Hopkins suggests that quitting the habit may actually raise diabetes risk in the short term.

A new study conducted at Israel's Ben-Gurion University of the Negev reveals that Celebrex (celecoxib) and other anti-inflammatory coxib medications may counter the positive effects of aspirin in preventing blood clots.

While there's nothing wrong with drinking some beer, wine, champagne or other spirits at the big New Year's Eve bash, too many people overdo it and find themselves waking up on New Year's Day with a terrible  headache and a queasy stomach.

Headaches and heartaches. Broken bones and broken spirits. Hurting bodies and hurt feelings. We often use the same words to describe physical and mental pain.

McNeil Consumer Healthcare is expanding its recall to include all available product lots of Tylenol Arthritis Pain Caplet 100-count bottles with the red EZ-OPEN cap.

The Procter & Gamble Company has announced it is recalling its Vicks DayQuil Cold & Flu 24-count liquicaps bonus pack in the U.S.

Atlas Operations, Inc., has announced it is recalling its dietary supplements for sexual enhancement sold under specific lot numbers.

An article published in the peer-reviewed journal Women's Health emphasizes the importance of early pregnancy detection. Using research conducted on behalf of First Response maker Church & Dwight Co. Inc., the article reviews data that shows not all at-home pregnancy tests are created equal.

Bayer Consumer is recalling a single product lot of the combination package of Alka-Seltzer Plus Day & Night Cold Formula Liquid Gels.

Merck has announced that the FDA has approved Zegerid OTC (omeprazole 20 mg/sodium bicarbonate 1,100 mg capsules), for over-the-counter treatment of frequent heartburn.